Pharmaceuticals, Biotechnology and Life Sciences
SAN CARLOS, Calif., Oct. 23, 2022 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity…
FLORHAM PARK, N.J., Oct. 23, 2022 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing…
– Clinical and in vitro data presented in three late-breaking presentations at ATA provide emerging evidence of VRDN-001 efficacy and…
LOS ANGELES, Oct. 21, 2022 (GLOBE NEWSWIRE) — On October 17, 2022, Enochian BioSciences, Inc. (the “Company”) received a notice…
MORRISVILLE, N.C., Oct. 21, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release…
Daix (France), Long Island City (New York, United States), October 21, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA,…
Data are based on analysis of the first 100 patients from an ongoing Phase 2b study of patients who have…
Orion Corporation NOTIFICATION 21.10.2022 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 21.10.2022 Date 21.10.2022 Exchange transaction Buy …
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2022 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company…